Unknown

Dataset Information

0

Human oligodendroglial cells express low levels of C1 inhibitor and membrane cofactor protein mRNAs.

ABSTRACT: BACKGROUND: Oligodendrocytes, neurons, astrocytes, microglia, and endothelial cells are capable of synthesizing complement inhibitor proteins. Oligodendrocytes are vulnerable to complement attack, which is particularly observed in multiple sclerosis. This vulnerability may be related to a deficiency in their ability to express complement regulatory proteins. METHODS: This study compared the expression level of complement inhibitor mRNAs by human oligodendrocytes, astrocytes and microglia using semi-quantitative RT-PCR. RESULTS: Semi-quantitative RT-PCR analysis showed that C1 inhibitor (C1-inh) mRNA expression was dramatically lower in oligodendroglial cells compared with astrocytes and microglia. The mRNA expression level of membrane cofactor protein (MCP) by oligodendrocytes was also significantly lower than for other cell types. CONCLUSION: The lower mRNA expression of C1-inh and MCP by oligodendrocytes could contribute to their vulnerability in several neurodegenerative and inflammatory diseases of the central nervous system.

SUBMITTER: Hosokawa M 

PROVIDER: S-EPMC516791 | biostudies-literature | 2004 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Human oligodendroglial cells express low levels of C1 inhibitor and membrane cofactor protein mRNAs.

Hosokawa Masato M   Klegeris Andis A   McGeer Patrick L PL  

Journal of neuroinflammation 20040824 1

BACKGROUND: Oligodendrocytes, neurons, astrocytes, microglia, and endothelial cells are capable of synthesizing complement inhibitor proteins. Oligodendrocytes are vulnerable to complement attack, which is particularly observed in multiple sclerosis. This vulnerability may be related to a deficiency in their ability to express complement regulatory proteins. METHODS: This study compared the expression level of complement inhibitor mRNAs by human oligodendrocytes, astrocytes and microglia using s  ...[more]

Similar Datasets

Unknown Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor.
| S-EPMC7690775 | biostudies-literature
Unknown Low Levels of IgM and IgA Recognizing Acetylated C1-Inhibitor Peptides Are Associated with Systemic Lupus Erythematosus in Taiwanese Women.
| S-EPMC6539680 | biostudies-other
Unknown Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels.
| S-EPMC4957703 | biostudies-literature
Unknown Complement C1 esterase inhibitor levels linked to infections and contaminated heparin-associated adverse events.
| S-EPMC3325920 | biostudies-literature
Unknown Membrane cofactor protein (MCP; CD46): deficiency states and pathogen connections.
| S-EPMC8123722 | biostudies-literature
Unknown Crystal structure of protein Z-dependent inhibitor complex shows how protein Z functions as a cofactor in the membrane inhibition of factor X.
| S-EPMC2766681 | biostudies-literature
Unknown Human neutrophils express low levels of FcγRIIIA, which plays a role in PMN activation.
| S-EPMC6484458 | biostudies-literature
Unknown Cooperative regulation of C1-domain membrane recruitment polarizes atypical protein kinase C.
| S-EPMC10435729 | biostudies-literature
Unknown Functional properties of membrane cofactor protein of complement.
| S-EPMC1133618 | biostudies-other
Unknown Design of amphiphilic protein maquettes: controlling assembly, membrane insertion, and cofactor interactions.
| S-EPMC2574520 | biostudies-literature